Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 19.21
-0.02 (-0.10%)
Sep 8, 2025, 2:45 PM CST
SHE:000623 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,295 | 1,551 | 1,460 | 1,781 | 1,781 | 1,709 | Upgrade |
Depreciation & Amortization | 223.44 | 233.37 | 233.87 | 225.63 | 204.16 | 195.46 | Upgrade |
Other Amortization | 5.78 | 4.98 | 5.79 | 4.85 | 4.03 | 3.89 | Upgrade |
Loss (Gain) From Sale of Assets | 0.28 | 0.67 | -36.16 | -3.16 | 0.94 | 0.64 | Upgrade |
Asset Writedown & Restructuring Costs | 65.54 | 65.33 | 3.25 | 1.67 | 2.84 | 25.53 | Upgrade |
Loss (Gain) From Sale of Investments | -2,601 | -1,733 | -1,238 | -1,005 | -1,748 | -1,762 | Upgrade |
Provision & Write-off of Bad Debts | 2.41 | - | -4.64 | 11.62 | 5.15 | -0.57 | Upgrade |
Other Operating Activities | 82.59 | 94.85 | 184.7 | 188.3 | 143.12 | 127.91 | Upgrade |
Change in Accounts Receivable | 243.11 | 268.54 | -304.33 | -189.01 | 6.42 | 58.67 | Upgrade |
Change in Inventory | 18.43 | -113.74 | -16.93 | -301.23 | -59.61 | -20.54 | Upgrade |
Change in Accounts Payable | -160.45 | -254.64 | -97.31 | 443.58 | 31.83 | 64.19 | Upgrade |
Change in Other Net Operating Assets | -26.52 | -32.24 | -118.56 | -610.91 | - | - | Upgrade |
Operating Cash Flow | 232.84 | 59.48 | 68.06 | 423.86 | 324.85 | 390.41 | Upgrade |
Operating Cash Flow Growth | -30.17% | -12.60% | -83.94% | 30.48% | -16.79% | 2.89% | Upgrade |
Capital Expenditures | -152.48 | -273.98 | -419.52 | -270.97 | -313.3 | -227.38 | Upgrade |
Sale of Property, Plant & Equipment | 3.29 | 3.92 | 34.61 | 3.08 | 36.94 | 1.42 | Upgrade |
Cash Acquisitions | - | - | - | -2.13 | - | -0.95 | Upgrade |
Investment in Securities | -37.79 | -0.68 | 524.4 | -1,112 | -1,081 | -96.57 | Upgrade |
Other Investing Activities | 1,187 | 707.19 | 624.13 | 828.75 | 646.6 | 508.69 | Upgrade |
Investing Cash Flow | 999.92 | 436.44 | 763.62 | -553.21 | -710.4 | 185.21 | Upgrade |
Short-Term Debt Issued | - | 3,571 | 653.05 | 641.98 | 302.36 | 306.86 | Upgrade |
Total Debt Issued | 1,341 | 3,571 | 653.05 | 641.98 | 302.36 | 306.86 | Upgrade |
Short-Term Debt Repaid | - | -3,319 | -651.69 | -374.93 | -342.38 | -21.56 | Upgrade |
Total Debt Repaid | -1,639 | -3,319 | -651.69 | -374.93 | -342.38 | -21.56 | Upgrade |
Net Debt Issued (Repaid) | -298.32 | 252.23 | 1.36 | 267.05 | -40.02 | 285.3 | Upgrade |
Repurchase of Common Stock | -420.01 | -300 | -150 | -170.04 | -100 | -300.03 | Upgrade |
Common Dividends Paid | -1,023 | -1,060 | -400.57 | -377.76 | -255.71 | -252.3 | Upgrade |
Other Financing Activities | -4 | -2.2 | - | 109.68 | 33.32 | -16.47 | Upgrade |
Financing Cash Flow | -1,745 | -1,110 | -549.21 | -171.07 | -362.4 | -283.51 | Upgrade |
Foreign Exchange Rate Adjustments | -0.14 | -0.25 | -0.72 | -4.12 | 1.73 | 4.02 | Upgrade |
Net Cash Flow | -512.47 | -614.29 | 281.75 | -304.55 | -746.23 | 296.13 | Upgrade |
Free Cash Flow | 80.36 | -214.5 | -351.46 | 152.89 | 11.54 | 163.02 | Upgrade |
Free Cash Flow Growth | - | - | - | 1224.31% | -92.92% | 3.80% | Upgrade |
Free Cash Flow Margin | 3.46% | -8.22% | -10.19% | 5.33% | 0.50% | 7.24% | Upgrade |
Free Cash Flow Per Share | 0.07 | -0.18 | -0.27 | 0.12 | 0.01 | 0.13 | Upgrade |
Cash Income Tax Paid | 182.08 | 218.53 | 304.37 | 205.93 | 207.45 | 286.46 | Upgrade |
Levered Free Cash Flow | -241.51 | -254.86 | -526.06 | -2.86 | -139.08 | 12.79 | Upgrade |
Unlevered Free Cash Flow | -208.08 | -197.3 | -435.84 | 86.51 | -57.53 | 92.05 | Upgrade |
Change in Working Capital | 158.05 | -158.33 | -540.95 | -781.03 | -67.95 | 90.19 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.